Bod says its softgel product could be the ‘benchmark delivery format’ for over-the-counter CBD by Martin Lane November 23, 2022November 23, 2022 Bod Australia has announced positive results from a Phase 1 pharmacokinetic (PK) study evaluating its ECS […]
Cann Group looks to raise another A$10m for Mildura, puts Southern facility up for sale by Martin Lane October 25, 2022October 27, 2022
Company news: Bod; Incannex; Medlab; Rua Bioscience; Emyria by Martin Lane October 20, 2022August 16, 2023
Researchers discover therapeutic potential of CBD for Parkinson’s sufferers by Martin Lane October 11, 2021October 11, 2021
Company news: Bod Australia; Zelira Therapeutics; Creso Pharma; Emyria; AusCann; Allied Corp by Martin Lane September 23, 2021September 23, 2021